Department of Medicine I and Clinical Chemistry, University of Heidelberg, Heidelberg, Germany.
J Surg Oncol. 2012 Jun 1;105(7):679-86. doi: 10.1002/jso.22101. Epub 2011 Sep 29.
This retrospective study of 73 myeloma patients with painful vertebral lesions compares clinical and radiomorphological outcomes up to 2 years after additional kyphoplasty, radiation therapy or systemic treatment only.
We assessed pain, disability and radiomorphological parameters by visual analogue scale (VAS 0-100), Oswestry Disability Index and by re-evaluating available follow-up X-rays, respectively, in patients that were treated according to a clinical pathway.
After 2 years the VAS score was reduced in all groups by 66 ± 8.2 (kyphoplasty), 35 ± 10.5 (radiation therapy) and 38 ± 20.5 (systemic therapy only). Only after kyphoplasty we observed a significantly reduced Oswestry Disability Index after 1 year (P < 0.001). Vertebral height remained stable after kyphoplasty (P = 0.283), in contrast to a progressive height loss in the other groups (P = 0.013 and P = 0.015 for radiation and systemic therapy only, respectively). Two years after kyphoplasty and radiotherapy the overall vertebral fracture incidence was significantly decreased as compared to the group after systemic therapy only (9.7% of all thoracic and lumbar vertebrae had new vertebral fractures after systemic therapy only, 2% after kyphoplasty (P < 0.001), 4.8% after radiation (P = 0.032)).
Additional kyphoplasty was more effective than additional radiation or systemic therapy in terms of pain relief, reduction of pain associated disability and reduction of fracture incidence of the entire lumbar and thoracic spine.
本回顾性研究纳入 73 例伴有疼痛性椎体病变的骨髓瘤患者,比较了经皮椎体后凸成形术、放射治疗或单纯全身治疗后 2 年内的临床和放射影像学结局。
我们通过视觉模拟评分(VAS 0-100)、Oswestry 功能障碍指数(ODI)和重新评估现有随访 X 线片评估疼痛、残疾和放射影像学参数,分别评估根据临床路径治疗的患者。
2 年后,所有组的 VAS 评分均降低了 66±8.2(经皮椎体后凸成形术)、35±10.5(放射治疗)和 38±20.5(单纯全身治疗)。只有经皮椎体后凸成形术后,我们观察到 1 年后 Oswestry 功能障碍指数显著降低(P<0.001)。经皮椎体后凸成形术后椎体高度保持稳定(P=0.283),而其他组则出现高度进行性丢失(P=0.013 和 P=0.015,分别为单纯放射治疗和单纯全身治疗)。经皮椎体后凸成形术和放射治疗后 2 年,与单纯全身治疗组相比,总体椎体骨折发生率显著降低(单纯全身治疗组所有胸腰椎中,新发生椎体骨折占 9.7%,经皮椎体后凸成形术组为 2%(P<0.001),放射治疗组为 4.8%(P=0.032))。
在缓解疼痛、减轻与疼痛相关的残疾和降低整个胸腰椎骨折发生率方面,经皮椎体后凸成形术优于放射治疗或全身治疗。